1. Home
  2. Live Updates
  3. Hematologic malignancies

Live Breaking News & Updates on Hematologic malignancies

Stay informed with the latest breaking news from Hematologic malignancies on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Hematologic malignancies and stay connected to the pulse of your community

A Medical Oncologist's Insights on Cannabis Use in the Care of Patients With Hematologic Malignancies

Lindsay Wilde, MD, explains when cannabis may be appropriate and how she’s seen the agent affect quality of life for her patients.

New-jersey , United-states , Philadelphia , Pennsylvania , Delaware , American , Brooke-worster , Lindsay-wilde , Jefferson-health , Leukemia-program , American-cancer-society , American-cancer-society-action-network

MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL

MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United-states , Florida , California , Miami , San-diego , American , Mehrdad-mobasher , American-society-of-hematology-annual-meeting-exposition , American-society-of-hematology , International-congress-on-hematologic-malignancies , Chief-medical-officer , Annual-international-congress

Nirmatrelvir/Ritonavir in Patients With Hematologic Malignancies Improves COVID-19 Outcomes

Early treatment administration with this regimen also promoted a faster decrease in viral load and shorter viral shedding in patients with hematologic diseases who were positive for COVID-19.

Gilead-sciences , Pfizer , Hematologic-malignancies , Treatment-regimens ,

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Boston , Massachusetts , Georgia , Atlanta , Risvodetinib-risvo , Miltonh-werner , Risvodetinib-ik , Company-contact , Youtube , Exchange-commission , Inhibikase-therapeutics-inc

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity

Company to host conference call on Thursday, March 28, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, March 27, 2024 -- Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing...

Massachusetts , United-states , Georgia , Atlanta , Boston , Risvodetinib-ik , Miltonh-werner , Risvodetinib-risvo , Alex-lobo , Stern-investor-relations-inc , Linkedin , Youtube

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity

Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , Massachusetts , Boston , Atlanta , Alex-lobo , Risvodetinib-risvo , Miltonh-werner , Risvodetinib-ik , Linkedin , Inhibikase-therapeutics-inc , Division-of-hematologic-malignancies

Amer Zeidan, MBBS, MHS, Appointed Inaugural Chief of the Division of Hematologic Malignancies

Amer Zeidan, MBBS, MHS, has been appointed inaugural chief of the Division of Hematologic Malignancies at Yale Cancer Center.

Jordan , Amer-zeidan , University-of-jordan-school-medicine , Yale-school-of-medicine , Clinical-trials-office , Yale-cancer-center , Hematologic-malignancies , Yale-cancer , Jordan-school , Rochester-general-hospital , Rochester-general , Johns-hopkins-medicine

FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer

SAN FRANCISCO, March 11, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Deyaa Adib, M.D., an executiv...

Cairo , Al-qahirah , Egypt , China , Cairo-university , Al-jizah , Japan , United-states , Boston , Massachusetts , American , Meichiel-keenan

Dr Saeed on the Use of Pola-R-CHP in Previously Untreated DLBCL

Hayder Saeed, MD, discusses key takeaways regarding the use of polatuzumab vedotin plus R-CHP in diffuse large B-cell lymphoma.

Hayder-saeed , International-prognostic-index , Moffitt-cancer-center , Malignant-hematology , Bridging-the-gaps , Hematologic-malignancies ,

Dr Danilov on Addressing Unmet Needs in Hematologic Malignancies

Alexey Danilov, MD, PhD, discusses unmet needs in hematologic malignancies to be discussed at the Bridging The Gaps in Hematologic Malignancies meeting.

Alexey-danilov , Division-of-leukemia , Department-of-hematology-hematopoietic-cell-transplantation , Toni-stephenson-lymphoma-center , Hematopoietic-cell-transplantation , Bridging-the-gaps , Hematologic-malignancies ,